Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clint Pecenka

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
BMC Medicine|April 2, 2023
Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspectiveRachel Wittenauer, Clint Pecenka, Ranju Baral
Vaccine|February 18, 2024
Lassa fever vaccine use cases and demand: Perspectives from select West African expertsLassané Kaboré, Clint Pecenka, William P Hausdorff
Vaccine|February 1, 2024
Costs of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic reviewRose Slavkovsky, Emily Callen, Clint Pecenka, et al.
BMJ Open|April 25, 2021
Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort modelRanju Baral, Deborah Higgins, Katie Regan, et al.
Human Vaccines & Immunotherapeutics|March 4, 2022
Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling studyFrédéric Debellut, Clint Pecenka, William P Hausdorff, et al.
BMC Health Services Research|July 4, 2025
Cost-effectiveness and benefit-risk of rotavirus vaccination in Afghanistan: a modelling analysis informed by post-licensure surveillancePalwasha Anwari, Frédéric Debellut, Sardar Parwiz, et al.
Pharmacoeconomics|March 7, 2026
Correction: Estimating the Value of Combination Vaccines: A Methodological FrameworkMark Jit, Allison Portnoy, Clint Pecenka, et al.
Pharmacoeconomics|January 4, 2026
Estimating the Value of Combination Vaccines: A Methodological FrameworkMark Jit, Allison Portnoy, Clint Pecenka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2021
A Financial and Global Demand Analysis to Inform Decisions for Funding and Clinical Development of Group B Streptococcus Vaccines for Pregnant WomenStefano Malvolti, Clint Pecenka, Carsten F Mantel, et al.
Plos One|August 21, 2020
Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverageRanju Baral, Jessica Fleming, Sadaf Khan, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
BMC Medicine|April 2, 2023
Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspectiveRachel Wittenauer, Clint Pecenka, Ranju Baral
Vaccine|February 18, 2024
Lassa fever vaccine use cases and demand: Perspectives from select West African expertsLassané Kaboré, Clint Pecenka, William P Hausdorff
Vaccine|February 1, 2024
Costs of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic reviewRose Slavkovsky, Emily Callen, Clint Pecenka, et al.
BMJ Open|April 25, 2021
Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort modelRanju Baral, Deborah Higgins, Katie Regan, et al.
Human Vaccines & Immunotherapeutics|March 4, 2022
Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling studyFrédéric Debellut, Clint Pecenka, William P Hausdorff, et al.
BMC Health Services Research|July 4, 2025
Cost-effectiveness and benefit-risk of rotavirus vaccination in Afghanistan: a modelling analysis informed by post-licensure surveillancePalwasha Anwari, Frédéric Debellut, Sardar Parwiz, et al.
Pharmacoeconomics|March 7, 2026
Correction: Estimating the Value of Combination Vaccines: A Methodological FrameworkMark Jit, Allison Portnoy, Clint Pecenka, et al.
Pharmacoeconomics|January 4, 2026
Estimating the Value of Combination Vaccines: A Methodological FrameworkMark Jit, Allison Portnoy, Clint Pecenka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2021
A Financial and Global Demand Analysis to Inform Decisions for Funding and Clinical Development of Group B Streptococcus Vaccines for Pregnant WomenStefano Malvolti, Clint Pecenka, Carsten F Mantel, et al.
Plos One|August 21, 2020
Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverageRanju Baral, Jessica Fleming, Sadaf Khan, et al.
Pageof 10